Regulations.gov document
WN Pharmaceuticals, Inc. - Trunature CLA (conjugated linoleic acid) - Helps promote fat…
Other · FDA-2011-S-0932 · posted Jun 15, 2017
Key facts
| Document ID | FDA-2011-S-0932-1542 |
|---|---|
| Title | WN Pharmaceuticals, Inc. - Trunature CLA (conjugated linoleic acid) - Helps promote fat reduction and increased lean muscle mass |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2011-S-0932 |
| Posted | Jun 15, 2017 |
| Comment period opens | Jun 15, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: